Publication Name	World Journal of Clinical Oncology
Manuscript ID	19284
Country	Spain

Received	2015-05-03 11:14
Peer-Review Started	2015-05-03 20:41
To Make the First Decision	2015-06-03 14:41
Return for Revision	2015-06-04 18:01
Revised	2015-06-17 23:28
Second Decision	2015-06-24 08:30
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-07-02 16:31
Articles in Press	2015-07-02 16:31
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-07-23 15:14
Publish the Manuscript Online	2015-08-17 16:41

ISSN	2218-4333 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Editorial
Article Title	Oligometastatic disease, the curative challenge in radiation oncology
Manuscript Source	Invited Manuscript
All Author List	Amalia Palacios-Eito and Sonia García-Cabezas
Funding Agency and Grant Number
Corresponding Author	Amalia Palacios-Eito, PhD, Servicio de Oncología Radioterápica, Hospital Universitario Reina Sofía, Avda. Menéndez Pidal, s/n, 14004 Córdoba, Spain. amalia.palacios.sspa@juntadeandalucia.es
Key Words	Oligometastases; Radiotherapy; Stereotactic body radiotherapy; Stereotactic body radiation therapy; Stereotactic ablative body radiotherapy; Curative intent
Core Tip	Surgery has been shown to be able to cure a proportion of oligometastatic patients. Surgery limi-tations, either technical or due to refusal, advanced age, or associated comorbidity, have led to progressive implementation of stereotactic body radiation therapy (SBRT) as an alternative local ablative weapon. SBRT has been shown to be safe and effective and to achieve local control rates around 80%, with a variable impact on survival depending on other associated prognostic factors. Despite its good results, SBRT still faces significant clinical challenges, including identification of optimal patients to be treated.
Publish Date	2015-08-17 16:41
Citation	Palacios-Eito A, García-Cabezas S. Oligometastatic disease, the curative challenge in radiation oncology. World J Clin Oncol 2015; 6(4): 30-34
URL	http://www.wjgnet.com/2218-4333/full/v6/i4/30.htm
DOI	http://dx.doi.org/10.5306/wjco.v6.i4.30

Full Article (PDF)	WJCO-6-30.pdf
Full Article (Word)	WJCO-6-30.doc
Manuscript File	19284-Review.docx
Answering Reviewers	19284-Answering reviewers.pdf
Audio Core Tip	19284-Audio core tip.aif
Conflict-of-Interest Disclosure Form	19284-Conflict-of-interest statement.pdf
Copyright License Agreement	19284-Copyright assignment.pdf
Supplementary Material	19284-Supplementary material.pdf
Peer-review Report	19284-Peer-review(s).pdf
Scientific Misconduct Check	19284-Scientific misconduct check.pdf
Scientific Editor Work List	19284-Scientific editor work list.pdf